Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cage Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
Cage Bio

Cage Bio

Series A

Cage Bio: Innovating dermatology and immunology solutions for inflammation.

HQ
San Mateo, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Cage Bio, founded with a mission to innovate in dermatology and immunology, focuses on developing novel products for treating inflammation-related conditions. The company aims to address unmet medical needs in these fields through advanced research and technology. Their product portfolio includes treatments for atopic dermatitis and other inflammatory skin diseases, targeting both the dermatology and broader immunology markets.

Notable figures associated with Cage Bio include members of their Board of Directors and Scientific Advisory Board, who bring extensive expertise in medical research and business strategy. The company has achieved significant milestones, such as positive Phase 2 clinical trial results for their atopic dermatitis treatment. Cage Bio's innovations have the potential to significantly impact patient care in dermatology and immunology, offering new solutions for chronic inflammatory conditions.

Cage Bio - Similar Companies

DermBiont logo

DermBiont

dermbiont.com

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

arcutis.com

HI-Bio logo

HI-Bio

hibio.com

Larrk Bio logo

Larrk Bio

Castle Creek Biosciences logo

Castle Creek Biosciences

10xBio logo

10xBio

10xbio.com

Cadenza Bio logo

Cadenza Bio

cadenza.bio

Soltego logo

Soltego

soltego.com

CasTag Biosciences logo

CasTag Biosciences

Equillium logo

Equillium

equilliumbio.com

Naked Biome logo

Naked Biome

Cellular Approaches logo

Cellular Approaches

CarthroniX logo

CarthroniX

carthronix.com

Vyne Therapeutics logo

Vyne Therapeutics

Vilacto Bio logo

Vilacto Bio

vilacto.com

Cage Bio - Quick Facts

Who are Cage Bio's competitors?

Companies similar to Cage Bio include DermBiont, Arcutis Biotherapeutics, HI-Bio and Larrk Bio.

When was Cage Bio founded?

Cage Bio was founded in 2016.

Where is Cage Bio's headquarters located?

Cage Bio's headquarters is located in San Mateo, CA, US.

When was Cage Bio's last funding round?

Cage Bio's most recent funding round was for $7.2M (USD) in February 2021.

How much has Cage Bio raised to-date?

As of Feb 16, 2021, Cage Bio has raised a total of $12.7M (USD).

How many employees does Cage Bio have?

Cage Bio has 8 employees as of Feb 5, 2024.

Cage Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Dermatology
  • Immunology
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified